What is NVST's health score?

Envista Holdings Corp (NVST) has a TradeApes health score of 58 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NVST's estimated fair value?

Based on our 5-year discounted cash flow model, Envista Holdings Corp's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is NVST undervalued or overvalued?

Our model currently rates NVST as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

1 free score card remaining

Envista Holdings Corp (NVST)

Healthcare Overvalued low mixed

$26.71

Updated: 2026-07-15

TradeApes Score

Financial Strength

80 Strong

Operating Trend

50 Mixed

Relative Value

35 Weak

Capital Allocation

55 Mixed

Risk Management

80 Strong

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

Industry Related Stocks

Adagio Medical Holdings, Inc. (ADGM) ADM TRONICS UNLIMITED, INC. (ADMT) AETHLON MEDICAL INC (AEMD) Axe Compute Inc. (AGPU) ALIGN TECHNOLOGY INC (ALGN) ALLURION TECHNOLOGIES, INC. (ALUR)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.